HemoGenyx Pharmaceuticals Plc (HOPHF)
2.33
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
HemoGenyx Pharmaceuticals Cash and Short Term Investments (Annual) : 2.134M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 2.134M |
| December 31, 2024 | 0.1995M |
| December 31, 2023 | 1.590M |
| December 31, 2022 | 3.047M |
| December 31, 2021 | 9.266M |
| Date | Value |
|---|---|
| December 31, 2020 | 2.477M |
| December 31, 2019 | 0.6606M |
| December 31, 2018 | 2.245M |
| December 31, 2017 | 2.539M |
| December 31, 2016 | 3.488M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Silence Therapeutics Plc | 85.11M |
| Biodexa Pharmaceuticals Plc | 11.48M |
| NuCana Plc | 32.62M |
| Mereo BioPharma Group Plc | 40.99M |
| Compass Pathways Plc | 149.99M |